In March 2010, as previously reported on this web site, a federal court judge initially ruled that the patents on the BRCA1 and BRCA2 genes held by Myriad Genetics and the University of Utah “are directed to a law of nature and were therefore improperly granted.”
Filed under: Diagnosis, Management | Tagged: BRCA, gene, Myriad Genetics, patent | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site
